ABUS Forecast and Technical Stock AnalysisSell candidate since 2019-07-18 Loss -11.28%
Arbutus Biopharma Corporation fell by -11.28% in the last day ( Friday, 19th Jul 2019 ) from $1.95 to $1.73 and has now fallen 6 days in a row. During day the stock fluctuated 20.95% from a day low at $1.72 to a day high of $2.08. The price has fallen in 6 of the last 10 days and is down by -23.11% for this period. Volume has increased in the last day by 254 868 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 605 397 shares bought and sold for approximately $1.05 million.
- 30 day high of the ABUS stock price was $2.74 and low was $1.71.
- 90 day high was $3.26 and low was $1.42.
- 52 week high for the Arbutus Biopharma Corporation - $12.60 and low - $1.42.
Arbutus Biopharma Corporation lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.49% during the next 3 months and, with 90% probability hold a price between $0.97 and $1.87 at the end of this period.
There are few to none technical positive signals at the moment. Arbutus Biopharma Corporation holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $2.13 and $2.00. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday July 12, 2019, which indicates further falls until a new bottom pivot has been found. Arbutus Biopharma Corporation gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 36 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.62 and $1.57.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Arbutus Biopharma Corporation finds support just below today's level at $1.62. If this is broken, then the next support from accumulated volume will be at $1.57 and $1.46.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.36 between high and low, or 20.95%. For the last week, the stock has had a daily average volatility of 10.60%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
10.60 %Average volatility
Very Low Low Medium High Very High
|ABUS $1.73 ($-0.22 -11.28%)|
ABUS is down $0.22 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ABUS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ABUS analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now